Long-term Safety and Efficacy of Efgartigimod in Patients With Generalised Myasthenia Gravis

被引：0

作者：

Meisel, A. ^{[1
,2
]}

Bril, V. ^{[3
,4
]}

Vu, T. ^{[5
]}

Karam, C. ^{[6
]}

Peric, S. ^{[7
]}

De Bleecker, J. ^{[8
]}

Murai, H. ^{[9
]}

Beydoun, S. ^{[10
]}

Pasnoor, M. ^{[11
]}

Guglietta, A. ^{[12
]}

Ulrichts, P. ^{[12
]}

T'joen, C. ^{[12
]}

Utsugisawa, K. ^{[13
]}

Verschuuren, J. ^{[14
]}

Mantegazza, R. ^{[15
]}

Howard, J. ^{[16
]}

机构：

[1] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany

[2] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany

[3] Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada

[4] Univ Toronto, Toronto, ON, Canada

[5] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA

[6] Univ Penn, Penn Neurosci Ctr, Philadelphia, PA USA

[7] Univ Belgrade, Univ Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia

[8] Ghent Univ Hosp, Ghent, Belgium

[9] Int Univ Hlth & Welf, Sch Med, Dept Neurol, Tokyo, Japan

[10] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA

[11] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA

[12] Argenx, Ghent, Belgium

[13] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan

[14] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands

[15] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy

[16] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

OPR-021

引用

页码：62 / 62

页数：1

共 50 条

[31] The long-term clinical outcome of myasthenia gravis in patients with thymoma
Bril, V
Kojic, J
Dhanani, A
[J]. NEUROLOGY, 1998, 51 (04) : 1198 - 1200
[32] Long-term prognostic analysis of thymectomized patients with myasthenia gravis
Liu, W
Tong, T
Ji, ZD
Zhang, ZH
[J]. CHINESE MEDICAL JOURNAL, 2002, 115 (02) : 235 - 237
[33] Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT plus ): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
Howard Jr, James F.
Bril, Vera
Vu, Tuan
Karam, Chafic
Peric, Stojan
De Bleecker, Jan L.
Murai, Hiroyuki
Meisel, Andreas
Beydoun, Said R.
Pasnoor, Mamatha
Guglietta, Antonio
Van Hoorick, Benjamin
Steeland, Sophie
T'joen, Caroline
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
[J]. FRONTIERS IN NEUROLOGY, 2024, 14
[34] Long-term treatment of myasthenia gravis with immunoadsorption
Haas, M
Mayr, N
Zeitlhofer, J
Goldammer, A
Derfler, K
[J]. JOURNAL OF CLINICAL APHERESIS, 2002, 17 (02) : 84 - 87
[35] Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses
Howard, James F., Jr.
Karam, Chafic
Yountz, Marcus
O'Brien, Fanny L.
Mozaffar, Tahseen
[J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (07): : 1398 - 1407
[36] LONG-TERM EFFICACY OF ECULIZUMAB IN REFRACTORY GENERALIZED MYASTHENIA GRAVIS: RESPONDER ANALYSES
Howard, James
Karam, Chafic
Yountz, Marcus
O'Brien, Fanny
Mozaffar, Tahseen
[J]. MUSCLE & NERVE, 2019, 60 : S133 - S133
[37] Safety of long-term combined immunosuppressive treatment in myasthenia gravis - analysis of adverse effects of 163 patients
Rozsa, C.
Lovas, G.
Fornadi, L.
Szabo, G.
Komoly, S.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (09) : 947 - 952
[38] Long-term cyclosporine treatment in a group of severe myasthenia gravis patients
Domenico Marco Bonifati
C. Angelini
[J]. Journal of Neurology, 1997, 244 : 542 - 547
[39] Long-term risk of generalization in patients with pure ocular myasthenia gravis
Alharbi, Mohammed
Aldehailan, Anas
Alqwaifly, Mohammed
Katzberg, Hans
Bril, Vera
Tapia, Carolina Barnett
[J]. NEUROLOGY, 2020, 94 (15)
[40] Long-term respiratory muscle endurance training in patients with myasthenia gravis
Rassler, B.
Hallebach, S.
Freitag, S.
Baumann, I.
Kalischewski, P.
[J]. ACTA PHYSIOLOGICA, 2014, 210 : 138 - 138

← 1 2 3 4 5 →